Exploring serotonergic psychedelics as a treatment for personality disorders

Area of Science:

• Psychiatry
• Neuroscience
• Psychopharmacology

Background:

• Psychotherapy and medications offer limited efficacy for personality disorders (PDs).
• Psychedelic therapy shows promise for psychiatric conditions often comorbid with PDs.
• Psychedelics may modulate personality, suggesting potential for PD treatment.

Purpose of the Study:

• To review the potential of psychedelic therapy for treating personality disorders.
• To examine psychedelic effects on personality through DSM-5-TR and DSM-AMPD frameworks.
• To discuss clinical relevance, safety, and future research directions.

Main Methods:

• Review of existing literature on psychedelics and PDs.
• Analysis through the lens of the DSM-5-TR categorical model.
• Examination using the dimensional DSM Alternative Model of Personality Disorders (DSM-AMPD).

Main Results:

• Limited rigorous research exists on psychedelics for PDs.
• Psychedelics may influence self-functioning, interpersonal functioning, and personality traits.
• Individuals with PDs are often excluded from current psychedelic trials.

Conclusions:

• Psychedelic therapy may offer a novel approach to treating personality pathology.
• Further research is crucial to establish efficacy and safety in PD populations.
• Consideration of safety and specific clinical approaches is necessary for this complex group.